Long-Term Remission of Peritoneal Lymphangiomatosis with Sirolimus Therapy: A Case Report with 8-Year Follow-Up
This case underscores the difficulty of diagnosing peritoneal lymphangiomatosis and highlights the transformative potential of sirolimus therapy. To our knowledge, this is one of the longest documented remissions of peritoneal lymphangiomatosis under mechanistic target of rapamycin (mTOR) inhibition.
Authors
- Mirela Bašić Denjagić
- Zijah Rifatbegović (ORCID: https://orcid.org/0000-0001-5287-5878)
- Jasminka Mustedanagić–Mujanović (ORCID: https://orcid.org/0000-0001-7277-0635)
- Ermina Iljazović
- Enver Zerem (ORCID: https://orcid.org/0000-0001-6906-3630)
- Lejla Tupković Rakovac (ORCID: https://orcid.org/0000-0002-1154-800X)
- Predrag Jovanović (ORCID: https://orcid.org/0000-0001-5547-5159)
- Ivana Čerkez (ORCID: https://orcid.org/0009-0003-1277-445X)
Institutions
- Academy of Sciences and Arts of Bosnia and Herzegovina (BA)
- University Clinical Center Tuzla (BA)
Publication Details
- Journal
- Case Reports in Gastroenterology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1159/000549801
- Citations
- 1
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- NIH Clinical Center